{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:04:32Z","timestamp":1784311472418,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"DOI":"10.7759\/cureus.112872","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:36:42Z","timestamp":1784309802000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety of Additional Local Anesthetics Soon After Liposomal Bupivacaine: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Daniella","family":"Veloria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S27894","article-title":"Liposomal bupivacaine: a review of a new bupivacaine formulation","volume":"5","author":"Chahar P","year":"2012","unstructured":"Chahar P, Cummings KC 3rd. Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res. 2012, 5:257-64. 10.2147\/JPR.S27894","journal-title":"J Pain Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-012-0043-z","article-title":"Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site","volume":"33","author":"Hu D","year":"2013","unstructured":"Hu D, Onel E, Singla N, Kramer WG, Hadzic A. Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site. Clin Drug Investig. 2013, 33:109-15. 10.1007\/s40261-012-0043-z","journal-title":"Clin Drug Investig"},{"key":"ref3","article-title":"Food and Drug Administration: Briefing Document, Anesthetic and Analgesic Drug Products Advisory Committee, February 14 and February 15, 2018","author":"U.S. Food and Drug Administration","year":"2018","unstructured":"U.S. Food and Drug Administration. FDA Briefing Information for the February 14-15, 2018 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee. U.S. Food and Drug Administration, Silver Spring (MD); 2018. https:\/\/www.fda.gov\/files\/advisory%20committees\/published\/FDA-Briefing-Information-for-the-February-14-15--2018-Meeti...."},{"key":"ref4","article-title":"Pacira Pharmaceuticals, Inc.: Exparel [2011 package insert]","author":"U.S. Food and Drug Administration","year":"2011","unstructured":"U.S. Food and Drug Administration. EXPAREL (Bupivacaine Liposome Injectable Suspension): Prescribing Information. U.S. Food and Drug Administration, Silver Spring (MD); 2011. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022496s000lbl.pdf."},{"key":"ref5","article-title":"Food and Drug Administration: Anesthetic and Analgesic Drug Products Advisory Committee Meeting, Thursday, February 15, 2018","author":"U.S. Food and Drug Administration","year":"2018","unstructured":"U.S. Food and Drug Administration. XPAREL (Bupivacaine Liposome Injectable Suspension): FDA Briefing Document for the February 14-15, 2018 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee. U.S. Food and Drug Administration, Silver Spring (MD); 2018. https:\/\/www.fda.gov\/media\/113063\/download."},{"key":"ref6","article-title":"Pacira Pharmaceuticals, Inc.: Exparel [2018 package insert]","author":"U.S. Food and Drug Administration","year":"2018","unstructured":"U.S. Food and Drug Administration. EXPAREL (Bupivacaine Liposome Injectable Suspension): Prescribing Information. U.S. Food and Drug Administration, Silver Spring (MD); 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022496s9lbl.pdf."},{"key":"ref7","article-title":"European Medicines Agency: Summary of Product Characteristics, Exparel","author":"European Medicines Agency","year":"2020","unstructured":"European Medicines Agency. Exparel Liposomal: EPAR - Product Information. European Medicines Agency, Amsterdam, Netherlands; 2020. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/exparel-liposomal-epar-product-information_en.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1335304","article-title":"Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation","volume":"17","author":"Aggarwal N","year":"2018","unstructured":"Aggarwal N. Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation. Expert Opin Drug Saf. 2018, 17:581-7. 10.1080\/14740338.2017.1335304","journal-title":"Expert Opin Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13561","article-title":"Incidence of adverse events attributable to bupivacaine liposome injectable suspension or plain bupivacaine for postoperative pain in pediatric surgical patients: a retrospective matched cohort analysis","volume":"29","author":"Cohen B","year":"2019","unstructured":"Cohen B, Glosser L, Saab R, et al.. Incidence of adverse events attributable to bupivacaine liposome injectable suspension or plain bupivacaine for postoperative pain in pediatric surgical patients: a retrospective matched cohort analysis. Paediatr Anaesth. 2019, 29:169-74. 10.1111\/pan.13561","journal-title":"Paediatr Anaesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm E","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61:344-9. 10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"ref11","article-title":"STRIDE--an integrated standards-based translational research informatics platform","volume":"2009","author":"Lowe HJ","year":"2009","unstructured":"Lowe HJ, Ferris TA, Hernandez PM, Weber SC. STRIDE--an integrated standards-based translational research informatics platform. AMIA Annu Symp Proc. 2009, 2009:391-5.","journal-title":"AMIA Annu Symp Proc"},{"key":"ref12","article-title":"National Bureau of Economic Research: ICD-9-CM to and from ICD-10-CM and ICD-10-PCS Crosswalk or General Equivalence Mappings","author":"National Bureau of Economic Research","year":"2010","unstructured":"National Bureau of Economic Research. ICD-9-CM to and from ICD-10-CM and ICD-10-PCS Crosswalk or General Equivalence Mappings. National Bureau of Economic Research, Cambridge (MA); 2010. https:\/\/www.nber.org\/research\/data\/icd-9-cm-and-icd-10-cm-and-icd-10-pcs-crosswalk-or-general-equivalence-mappings."},{"key":"ref13","article-title":"Healthcare Cost and Utilization Project: Surgery Flags for Services and Procedures","author":"Agency for Healthcare Research and Quality","year":"2023","unstructured":"Agency for Healthcare Research and Quality. Surgery Flags for Services and Procedures. Agency for Healthcare Research and Quality, Rockville (MD); 2023. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/surgeryflags_svcproc\/surgeryflagssvc_proc.jsp."},{"key":"ref14","article-title":"Healthcare Cost and Utilization Project: Clinical Classifications Software (CCS)","author":"Agency for Healthcare Research and Quality","year":"2023","unstructured":"Agency for Healthcare Research and Quality. Clinical Classifications Software (CCS) for ICD-10-PCS (Beta Version). Agency for Healthcare Research and Quality, Rockville (MD); 2023. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccs10\/ccs10.jsp."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.19626","article-title":"Association between preoperative hemodialysis timing and postoperative mortality in patients with end-stage kidney disease","volume":"328","author":"Fielding-Singh V","year":"2022","unstructured":"Fielding-Singh V, Vanneman MW, Grogan T, et al.. Association between preoperative hemodialysis timing and postoperative mortality in patients with end-stage kidney disease. JAMA. 2022, 328:1837-48. 10.1001\/jama.2022.19626","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven C","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009, 47:626-33. 10.1097\/MLR.0b013e31819432e5","journal-title":"Med Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples H","year":"2018","unstructured":"Samples H, Williams AR, Olfson M, Crystal S. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abuse Treat. 2018, 95:9-17. 10.1016\/j.jsat.2018.09.001","journal-title":"J Subst Abuse Treat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000544","article-title":"Incidence of local anesthetic systemic toxicity in orthopedic patients receiving peripheral nerve blocks","volume":"42","author":"M\u00f6rwald EE","year":"2017","unstructured":"M\u00f6rwald EE, Zubizarreta N, Cozowicz C, Poeran J, Memtsoudis SG. Incidence of local anesthetic systemic toxicity in orthopedic patients receiving peripheral nerve blocks. Reg Anesth Pain Med. 2017, 42:442-5. 10.1097\/AAP.0000000000000544","journal-title":"Reg Anesth Pain Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000684","article-title":"Local anesthetic systemic toxicity in total joint arthroplasty: incidence and risk factors in the United States from the National Inpatient Sample 1998-2013","volume":"43","author":"Rubin DS","year":"2018","unstructured":"Rubin DS, Matsumoto MM, Weinberg G, Roth S. Local anesthetic systemic toxicity in total joint arthroplasty: incidence and risk factors in the United States from the National Inpatient Sample 1998-2013. Reg Anesth Pain Med. 2018, 43:131-7. 10.1097\/AAP.0000000000000684","journal-title":"Reg Anesth Pain Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1474200","article-title":"A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database","volume":"17","author":"Dagenais S","year":"2018","unstructured":"Dagenais S, Scranton R, Joyce AR, Vick CC. A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database. Expert Opin Drug Saf. 2018, 17:545-52. 10.1080\/14740338.2018.1474200","journal-title":"Expert Opin Drug Saf"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/LRA.S154512","article-title":"Local anesthetic systemic toxicity: current perspectives","volume":"11","author":"El-Boghdadly K","year":"2018","unstructured":"El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth. 2018, 11:35-44. 10.2147\/LRA.S154512","journal-title":"Local Reg Anesth"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzu098","article-title":"What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system","volume":"27","author":"Westbrook JI","year":"2015","unstructured":"Westbrook JI, Li L, Lehnbom EC, et al.. What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system. Int J Qual Health Care. 2015, 27:1-9. 10.1093\/intqhc\/mzu098","journal-title":"Int J Qual Health Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512058-safety-of-additional-local-anesthetics-soon-after-liposomal-bupivacaine-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:36:43Z","timestamp":1784309803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512058-safety-of-additional-local-anesthetics-soon-after-liposomal-bupivacaine-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.112872","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}